ScreenerHero

LITSLite Strategy Inc. Common Stock

NAS · US · Healthcare · Biotechnology · litestrategy.com
0.9897USD+5.29%Mkt Cap: 33.67M $P/E: —

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed it…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap33.67M $
Enterprise Value24.56M $
Revenue (TTM)—
Gross Profit-1.97M $
Net Income (TTM)-15.95M $
Revenue/Share—
Last Price0.9897 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG2.22
EV/EBITDA-1.43
EV/Revenue—
P/S—
P/B0.58
EPS (TTM)-2.09
EPS (Forward)—
52W Range
0.68886% of range5.500
52W High5.500 USD
52W Low0.6888 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-94.18%
ROA-87.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.84M $
CapEx (TTM)—
FCF Margin—
FCF Yield-39.85%
Net Debt-7.54M $
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity—
Current Ratio11.53
Quick Ratio7.92
Book Value/Sh1.617 USD
Cash/Share0.2220 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 16, 2023
Pay DateDec 6, 2023
Splits
Last Split1:20
Split DateApr 17, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.34.03M
Float31.82M
Insiders1.16%
Institutions17.31%
Short Interest
Short Ratio0.7d
Short % Float0.38%
Short % Out.0.33%
Shares Short113.13K
Short (prev mo.)140.84K
Technical
SMA 500.9274 (+6.7%)
SMA 2001.219 (-18.8%)
Beta0.04
S&P 52W Chg18.16%
Avg Vol (30d)135.82K
Avg Vol (10d)115.35K
Technical Indicators
RSI (14)56.9
MACD-0.0091
MACD Signal-0.0109
MACD Hist.+0.0018
BB Upper1.022 USD
BB Middle0.9415 USD
BB Lower0.8609 USD
BB Width17.13%
ATR (14)0.0609 USD
Vol Ratio (20d)2.88x